Introduction
Infants with congenital heart disease are more likely to have low birth weight (LBW). The estimated incidence of LBW is approximately 8-23% of live born infants with congenital heart disease, and varies with the specific heart defect w1-3x. Over the last couple of decades, numerous single-institution reports have documented the increased morbidity and mortality associated with cardiac surgery in LBW neonates w4-9x. LBW neonates with congenital heart disease are frequently critically ill, premature, and suffer from non-cardiac organ dysfunction. Chromosomal defects or genetic syndromes may contribute to the LBW, and at the same time be independent risk factors for adverse outcomes following cardiac surgery. Just as there have been significant improvements in the outcomes following neonatal cardiac surgery, cardiac surgery in LBW babies has steadily shown improvement. However, LBW continues to be an independent risk factor for adverse outcome following corrective or palliative neonatal heart surgery.
It is difficult to prove that improved outcomes are afforded by a particular management strategy in any study relating low weight to cardiac surgery in infants. While significant delays for the sole purpose of weight gain should be avoided, cardiac surgery in LBW babies should be tailored to each patient's condition and associated factors. Using the principle of optimizing preoperative condition and promoting maturity, we report outcomes and risk factors of LBW infants having surgery for congenital heart disease in the current era.
Materials and methods

Patient population and outcome measures
The pediatric cardiac surgery database at the University of California, San Francisco was queried for all infants having heart surgery between January 2002 and January 2010. Infants weighing 2500 g or less (at birth andyor at time of surgery) were identified and retrospectively reviewed. Demographic, preoperative and follow-up characteristics were collected from in-hospital charts and Downloaded from https://academic.oup.com/icvts/article-abstract/12/3/409/759744 by guest on 02 February 2019 
Statistical analysis
All data are expressed as frequencies and median with ranges. Cumulative survival estimates are based on the Kaplan-Meier method. Comparisons of cumulative survival were made by non-parametric Wilcoxon test for equality of survival functions. Cox proportional hazards multivariate regression analysis was performed to adjust for covariates, including age, use of mechanical ventilation, extracorporeal life support (ECLS), use of prostaglandins, and use of Norwood procedure wor diagnosis of hypoplastic left heart syndrome (HLHS)x or univentricular palliation. Since followup information for mortality was available on all infants and seven out of eight deaths occurred within a year of surgery, raw estimates of overall mortality are also presented. x -tests were used to compare overall mortality 2 within groups of patients categorized on the basis of associated comorbidities. Analysis was carried out using STATA 11 software package (STATA corps, College Station, TX, USA). A P-value of 0.05 was empirically set as statistically significant. The study was approved by the Committee on Human Research at the University of California, San Francisco.
Results
Patient characteristics and diagnoses
Seventy-five low weight infants were identified. Tables 1  and 2 summarize demographic and diagnostic variables, respectively.
Operative features
The operative details are summarized in Table 3 .
Survival and postoperative outcomes
There were two early deaths. One child died after an air embolism from an intravenous line following a Norwood procedure. Another child, with single ventricle anatomy, died from progressive sepsis due to necrotizing enterocolitis. There were 73 perioperative survivors for an early survival of 97.3% w95% confidence interval (CI) 90.5-99.6%x. During the concurrent period, for 800 open cardiac surgical cases, the mortality was 0.8% for an overall 30-day survival of 99.2% (95% CI 98.4-99.7%). This difference in 30-day survival between the LBW study group and the overall group is not statistically significant (Ps0.09). Six patients had perioperative ECLS. There were an additional three inhospital deaths for a discharge mortality of 6.7%.
Follow-up was available on all infants with a median duration of 1320 days (range 6-3055 days). There were six additional deaths at five to 19 months postoperatively, yielding an overall mortality of 10.8% (95% CI, 4.7-20.1%). Overall mortality amongst patients with genetic or chromosomal abnormalities was higher, 28% vs. 5.4% amongst patients without such abnormalities (Ps0.008). There was no difference in overall mortality when patients were stratified on the basis prematurity, need for preoperative 
RACHS-1, Risk Adjustment for Congenital Heart Surgery-1. (Table 4) . Table 5 summarizes riskadjusted mortality by Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) class. Table 6 summarizes postoperative course and complications. Cumulative Kaplan-Meier survival at 30-day was 99% (95% CI, 91-100%), 90% (95% CI, 80-95%) at one year and 88% (95% CI, 77-94%) at five years (Fig. 1a) . Cumulative one-year Kaplan-Meier survival among patients without chromosomal or genetic abnormalities was higher 95% (95% CI, 83-98%) vs. 75% (95% CI, 46-90%) in infants with chromosomal or genetic anomalies (Ps0.009) (Fig. 1b) . Cumulative one-year Kaplan-Meier survival among patients born at -37-weeks' gestation was slightly lower at 83% (95% CI, 66-92%) vs. 97% (95% CI, 80-99.5%) among patients born at age of 37 weeks or greater (Fig. 1c) . However, this difference was not statistically significant (Ps0.084). Similarly, infants having palliative surgery had a slightly lower one-year cumulative survival, 88% (95% CI, 72-95%) vs. 91% (95% CI, 74-97%) among patients having complete surgical repair (Fig. 1d) . This difference too was not statistically significant (Ps0.4). In a multivariate Cox regression model including age of surgery, prematurity and presence or absence of preoperative mechanical ventilation the hazards of mortality among patients with chromosomal or genetic anomaly were 6.6 (95% CI 1.5-28.6), Ps0.01.
Discussion
A recent and important report of the Society of Thoracic Surgeons Congenital Heart Surgery Database analyzed outcomes of cardiac surgery in infants with LBW w10x. The study, one of the largest to date, reviewed mortality in over 3000 infants weighing 1-4 kg from 32 participating centers. Over 500 infants had LBW while the remaining 2505 weighed 2.5-4 kg. The low weight cohort had significantly higher mortality for specific operations including repair of coarctation of the aorta, repair of total anomalous pulmonary venous return (TAPVR), the arterial switch operation, systemic-to-pulmonary arterial shunt, and the Norwood procedure. Furthermore, lower weight consistently increased risk of death when the study population was stratified by RACHS-1 levels 2 through 6 and Aristotle Basic Complexity categories 2 through 4. For low weight patients having the Norwood procedure there was a trend for increased mortality when the procedure was undertaken in the first week of life. The study could not make any specific management recommendations for LBW infants having cardiac surgery and could not address the question of whether deferring surgical intervention for weight gain is advantageous. In the current series, 30-day and one-year mortality were 99% and 90%, respectively. There were no procedural risk factors and the major determinant of adverse outcome was presence of chromosomal or genetic anomaly. The overall survival data for LBW infants having cardiac surgery in our series is encouraging, and their outcomes are now approaching that of normal weight infants. 
Early mortality and one-year survival outcomes
In our series, there were 73 out of 75 early survivors for an overall 30-day/in-hospital mortality of 2.7%. The discharge mortality was 6.7%. Kaplan-Meier one-year survival was 90%. Reddy and colleagues reported a 10% early mortality and an additional 9% incidence of late deaths with a one-year actuarial survival of approximately 82% w9x. The main risk factor for adverse outcome in that series was prolonged cardiopulmonary bypass time. Pawade and colleagues reported 60 LBW babies having corrective or palliative cardiac surgery with the use of cardiopulmonary bypass w8x. Early mortality was 16% and late mortality was 13%. The overall actuarial survival at 100 months was 67%. Risk factors for death or adverse outcome in that series included: univentricular palliation, prolonged duration of cardiopulmonary bypass, and the occurrence of low cardiac output syndrome in the postoperative period. In a recent report, Ades and colleagues reported a hospital survival of 76% or 30-day in-hospital mortality of 24% in infants weighing -2500 g who had neonatal cardiac surgery w4x. Oneyear or beyond survival data was not provided. The main risk factor for death or adverse outcome in that series included the occurrence of cardiopulmonary arrest in the postoperative period necessitating cardiopulmonary resuscitation andyor extracorporeal membrane oxygenation (ECMO). The diagnosis of HLHS was also associated with higher risk of death in the early postoperative period.
Risk factors for outcomes
Patient-related risk factors
Preoperative end-organ injury was not a statistically significant risk factor for death and did not negatively impact one-year survival in our experience. Pawade et al. reported that preoperative acidosis, a marker for poor preoperative condition, had a negative impact on hospital survival w8x. This subgroup of infants may benefit from longer delays than usual, even once recovery of end-organ function is apparent, with the intent of maximizing recovery of even subclinical organ injury. The presence of prematurity showed a trend toward adverse outcome in our series, but was not statistically significant. Recent reports on current outcomes and factors associated with neonatal cardiac surgery have shown that prematurity can be an independent risk factor for hospital mortality even in normal weight infants. This subgroup of patients may obtain benefit by short, arbitrary delays in surgery in order to attain 'maturity' and not necessarily gain weight. The presence of an extra-cardiac malformation in our series was not a risk factor for adverse outcome. The presence of extra-cardiac malformations has been shown to negatively impact outcome following neonatal cardiac palliation. In a landmark report on successful staged palliation for HLHS, Bove and Lloyd reported that infants with associated congenital noncardiac anomalies were high risk w11x. Included in that category were infants that had LBW, were premature or had chromosomal anomalies. In our experience, the presence of a chromosomal or genetic anomaly did significantly impact survival in a negative way. Genetic abnormalities occur in approximately 15-20% of children with congenital heart disease. Neonates with genetic abnormalities usually have lower birth weights and experience delays in timing of surgery. Simsic et al. recently showed that while neonates with genetic abnormalities did have a higher risk of postoperative complications and a longer hospital length of stay, there was no increase in-hospital mortality w12x. Gestational age and weight are important risk factors for adverse outcomes, particularly at the lower end of the spectrum (i.e. gestational age -28 weeks and very LBW infants).
Procedural risk factors
Diagnosis of HLHS, performance of the Norwood procedure, or palliation for a univentricular heart has been reported as a risk factor for adverse outcome following cardiac surgery in LBW infants w4, 8-10, 13, 14x. In our series, HLHS andyor the Norwood procedure andyor palliation for univentricular heart were not risk factors for adverse outcome. It is difficult to determine the reason for neutralization of HLHS or univentricular palliation as a risk factor. It is possible that the use of the right ventricle to pulmonary artery conduit has conferred an advantage to stage I palliation and that advantage has been extended to LBW babies w15x.
Other groups have found the use of ECLS as a risk factor for adverse outcome following cardiac surgery in LBW infants w4x. Our experience concurs with the finding that perioperative ECLS negatively impacts survival, but was not statistically significant.
Study limitations
The study is limited by its retrospective nature. Furthermore, the patient population is a complex and heterogeneous one so the data cannot provide much insight into therapeutic strategies that may be advantageous. The relatively small number of subjects limits the power of the risk factor analysis. The study population may also contain a selection bias since we could not report outcomes for LBW cardiac surgical candidates who were not referred for surgery.
In summary, our experience suggests that cardiac surgery for LBW infants is improving. Many procedural and patient related risk factors can be neutralized. Currently, genetic defects may pose an immutable risk to cardiac operations in LBW infants. Modifying the phenotypic manifestations of anomalies of the chromosomal complement is an important challenge.
Conference discussion
Dr. G. Gargiulo (Bologna, Italy): I have two questions for you. My first question relates to the optimal timing for surgery and the best type of surgery. How do you choose the optimal timing for surgery? Have you lost any patients while waiting for stabilization or clinical problem resolution prior to surgery?
And how do you decide to perform a palliative surgery or corrective surgery in patients with biventricular anatomy, such as tetralogy of Fallot or pulmonary atresia with ventricular septal defect?
My second question relates to cerebral protection. Cerebral protection during extracorporeal circulation in this population is a very debated point. Have you seen in your experience any differences between this cohort and the population of normal weight neonates? Otherwise, have you seen a higher incidence of cerebral problems in the preterm group? Dr. Azakie: The first question relates to the optimal timing of surgeryhow do we decide when to operate on the child. And the second part of that question was what operation or what type of operation do you choose and how do you choose it? Excellent questions, and I will address the first one first.
With regard to ensuring the optimal preoperative condition, our preference is to try to get the babies extubated. We tolerate hypercarbia, minimize the prostaglandin dose, use supplemental caffeine as necessary and work towards extubation.
The institution of feeds is important in the critically ill baby because the use of trophic feeds may protect against bacteremia andyor a potential future risk of NEC. In some univentricular operations, we are not necessarily changing the physiology. So we think if we take the child to the operating room in better condition, then we will optimize the outcome.
Patients who have duct-dependent circulation, as you know, may suffer renal or hepatic injury. I think it is critical to ensure that renal and hepatic function completely normalize to avoid renal failure andyor coagulopathy with significant transfusion requirements in the postoperative period, putting the child at risk for TRALI, etc.
If there is a significant hemorrhage, then we like to wait at least one to two weeks to reduce the risk of expansion on bypass.
With regard to the type of operation, palliative vs. biventricular repair, I assume you are addressing specifically patients with a biventricular heart who can have a biventricular repair or a palliative procedure, such as is the case with tetralogy of Fallot or pulmonary atresia VSD. Early on in our experience, the preference was to perform a palliative operation, such as a shunt in those who had very small pulmonary arteries. But as our experience evolved, I think currently my preference would be to do a complete repair.
The reason for that is, as noted on one of the slides, the use of extracorporeal life support trended towards having a higher mortality risk, and the use of extracorporeal life support interestingly was most commonly used in patients who had shunted physiology in the setting of either single ventricle anatomy or a biventricular heart. So we are moving away from that. Unless, of course, the child has some other factors which preclude the use of bypass, such as a significant intraventricular hemorrhage. I think that answers the first question.
With regard to the second question, that revolved around the issues of neurological outcome in this patient cohort and the conduct of cardiopulmonary bypass.
Our approach to the conduct of bypass in this cohort is to use high-flow bypass 150-200 ccykgymin. We like to keep the hematocrit around 30%. When an arch reconstruction is being performed, we use selective cerebral perfusion at 30-50 ccykgymin and use near infrared spectroscopy to monitor the changes in cerebral oxygenation level.
The one time where I do prefer to use circulatory arrest is when we are doing a total veins repair. I think there is some association between prematurity and the development of pulmonary vein stenosis. And so when we are doing a total veins repair on a LBW, premature baby, it is useful and important to examine each vein very carefully and, in those selected cases, perform a primary sutureless repair of the pulmonary veins.
With regard to neurological outcome in this patient cohort, I think it is rather difficult sometimes to isolate an adverse neurological outcome to a single risk factor or single effect because this is such a heterogeneous patient population, and a wide array of factors can impact neurological outcome.
However, that being said, I do not have any data to support or show any differences between low birth weight and premature babies and normal birth weight or non-premature babies. We are in the process of collecting Bayley scales of infant development scores at one year and also are in the process of collecting pre-and postoperative MRI imaging, so that data is still pending.
Dr. B. Maruszewski (Warsaw, Poland): As you know, recently two huge cohort studies, STS and EACTS studies, have shown that low body weight below 2.5 kg was a risk factor for early death. The STS study suggests and showed that delaying surgery is not a good solution and actually makes the results worse.
But you have shown in your study that on the single institutional level, it is possible to neutralize the body weight as a risk factor for early death. Did you look at, or are you planning to look at, the other risk factors like surgical procedural risk factors, aortic cross-clamp time, systemic flow, and so on, to be able to show what in your technique makes this low body weight patient survive better than in the huge cohorts of multi-institutional studies on both sides of the Atlantic? Dr. Azakie: Good question. We have not looked at specific procedural factors such as cross-clamp time, bypass time, or flow rates to try and sort out exactly what management strategy allowed for improved outcomes.
In the STS multi-institutional studies, I think it was very difficult to show how a single management strategy can actually afford an improved outcome. Just as there are many factors which negatively affect cardiac surgical outcomes in low birth weight babies, there are probably a multitude of factors which can positively affect those outcomes when we implement a particular management strategy. So it is hard for me to answer that question. I think that at the extreme end, weight and age remain important risk factors. One other interesting thing we did in this study was we looked at or sought to determine the outcomes of isolated PDA ligation in a comparable group of babies.
Babies having PDA ligation share the 'low birth weight and prematurity' issues that the low birth weight, open surgery patients had. If babies having isolated PDA ligation suffered an adverse event, then it would be more likely explained by or attributed to patient-related risk factors rather than procedural factors, since they are having a curative operation without the use of cardiopulmonary bypass. Interestingly, the 30-day and one-year survival or mortality among low birth weight infants who had isolated PDA ligation was not statistically different from that of the LBW study group having open cardiac surgery. LBW infants having isolated PDA ligation in this series had a much lower median weight and more severe prematurity but they did have a lower incidence of chromosomalygenetic anomalies or extra-cardiac malformations, making it difficult to validate the comparison in such a heterogeneous population. The comparison does highlight, however, the impact that very low birth weight and prematurity have on survival outcomes in babies having a curative operation for a simple lesion.
Very low birth weight or significant prematurity are very significant risk factors for adverse outcome, and it will be difficult to neutralize that. Dr. Maruszewski: That is why we have excluded even the PDA group from the analysis and did it together and without, which makes a big difference.
